Market Tracker

09/17 3:19am ET

Enzon Pharmaceuticals Inc (NASDAQ:ENZN)

1.30
Data as of Sep 16
 -0.13 / -9.09%
Today’s Change
0.78
Today|||52-Week Range
1.83
+12.07%
Year-to-Date

Today’s Trading

Previous close1.43
Today’s open1.34
Day’s range1.27 - 1.40
Volume1,435,596
Average volume (3 months)678,888
Market cap$63.1M
Dividend yield--
Data as of 3:59pm ET, 09/16/2014

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-241.48%
Earnings growth (next 5 years)+53.00%
Revenue growth (last year)-19.03%
P/E ratio2.2
Price/Sales1.47
Price/Book12.00

Competitors

 Today’s
change
Today’s
% change
GTXIGTX Inc-0.04-4.29%
AVEOAveo Pharmaceuticals...-0.09-7.50%
OGXIOncoGenex Pharmaceut...-0.12-3.91%
CBRXColumbia Laboratorie...-0.01-0.17%
Data as of 3:59pm ET, 09/16/2014

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$34.5M
Annual profit (last year)$18.2M
Net profit margin52.62%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive &
Operating Officer
George W. Hebard
Chief Financial Officer &
Vice President-Finance
Richard L. Feinstein
Corporate headquarters
Piscataway, New Jersey

Forecasts